BPA Call 36C24221A0005-36C24222N0185

Award Date 10/1/21
Potential Completion Date 3/11/24
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Norcross, GA, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $127,045.25, was issued by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs. The contract was awarded to Immucor Inc., a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The contract is for the provision of blood bank reagents and is issued as a Blanket Purchase Agreement (BPA) call against Immucor's General Services...
This is a federal contract award to Immucor Inc., a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. The contract, with a ceiling value of $538,018.90, was awarded by the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 6, to provide BLOOD BANK REAGENTS under a Firm Fixed Price Delivery Order. The contract is not set aside and is issued under Immucor's existing General Services...
This federal contract award to Immucor Inc. is for the delivery of blood bank reagents and supplies testing to the Department of Veterans Affairs Veterans Health Administration. The $175,320.53 contract has a firm fixed price under the Invitro Diagnostics, Reagents, Test (FSS-65-VII) multiple award schedule contract vehicle. Immucor, a manufacturer of goods, has provided a variety of in vitro diagnostic products and testing equipment to federal agencies like the VA, Defense Health Agency, and...
This delivery order for $52,642.92 was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to Immucor Inc. to provide blood bank reagents in support of testing programs. The contract calls for reagents under Immucor's multiple award schedule contract for in vitro diagnostics, reagents, and test kits. The firm fixed price order has a period of performance through February 2024 and utilizes Immucor's established pricing under...
This federal contract award to Immucor Inc., a for-profit manufacturer of goods, was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 10. The contract is for the provision of REAGENTS, with a potential value of $302,806.50. The contract is a Blanket Purchase Agreement (BPA) Call under Immucor's General Services Administration (GSA) schedule for "Invitro Diagnostics, Reagents, Test (FSS-65-VII)". The contract is...
This federal contract award to Immucor Inc., a manufacturer of in vitro diagnostic reagents and test kits, is for the supply of blood banking reagents to the Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 4. The contract has a potential value of $451,136.09 and was awarded on a Firm Fixed Price basis under Immucor's General Services Administration (GSA) Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits. The contract supports...
This federal contract award to Immucor Inc. is for the provision of BLOOD BANK REAGENTS. The contract is a BPA Call, issued under Immucor's existing GSA Schedule 65-VII contract for in vitro diagnostics, reagents, and test kits. The contract has a ceiling value of $135,534.96 and a period of performance through September 30, 2026. The awarding agency is the Department of Veterans Affairs, specifically the Veterans Integrated Service Network 4, a civilian agency. This contract does not have a...
The Department of Veterans Affairs Veterans Health Administration awarded a $15,583 firm fixed price blanket purchase agreement call contract to Immucor Inc. to deliver blood bank reagents. Immucor will supply these immunology diagnostic test reagents to VA facilities in Veterans Integrated Service Network 2 under the terms of their existing GSA Schedule 65-VII contract for invitro diagnostics, reagents, and tests. The one year contract runs from October 2023 through September 2024 for...
This federal contract award, valued at $36,606.40, was issued by the Veterans Integrated Service Network 17 to Immucor Inc. for the supply of blood bank reagents. The contract is a Blanket Purchase Agreement (BPA) call order placed against Immucor's existing General Services Administration (GSA) schedule contract for in vitro diagnostics, reagents, and test kits. The award does not have a set-aside designation. As a leading provider of automated instrument-reagents systems and consumables for...
This is a federal contract award to Immucor Inc., a leading provider of automated instrument-reagents systems and consumables for blood transfusion and transplantation compatibility testing. The contract, valued at $122,621.21, is for the delivery of BLOOD BANK REAGENTS to the Veterans Integrated Service Network 4 (VISN 4), a civilian agency of the U.S. Department of Veterans Affairs. The contract is a Blanket Purchase Agreement (BPA) call issued under Immucor's existing General Services...

This federal contract award from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 provides $49,042.84 in potential value for blood bank reagents from Immucor Inc. under the firm fixed price contract type. No set-aside designation was utilized for this award made against Immucor's multiple award schedule contract vehicle for invitro diagnostics, reagents, test kits under Federal Supply Schedule 65-VII. The contract calls for delivery of blood bank reagents from Immucor, a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing, to support the testing programs and healthcare services of the VHA. Performance will take place in Norcross, Georgia through March 2024.

Generated 3/12/24, 10:27 PM